Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction

Journal of Clinical Pathology

Volumn 56, Issue 3, 2003, Pages 194-199

  Krijnen, P A J ^a   Meischl, C ^b   Hack, C E ^a   Meijer, C J L M ^a   Visser, C A ^a   Roos, D ^b   Niessen, H W M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; CELL AGING; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; DISEASE ASSOCIATION; GENE EXPRESSION; HEART DISEASE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NADH, NADPH OXIDOREDUCTASES; SPECIMEN HANDLING; UP-REGULATION;

EID: 0037340087     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.3.194     Document Type: Article

References (27)

1. Duranteau J, Chandel NS, Kulisz A, et al. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998;273:11619-24.
2. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992;70:593-9.
3. Abe J, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 2002;8:59-64.
4. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997;11:118-24.
5. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 1996;20:443-8.
6. von Harsdorf R, Li PF, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999;99:2934-41.
7. Lambeth JD, Cheng G, Arnold RS, et al. Novel homologs of gp91 phox. Trends Biochem Sci 2000;25:459-61.
8. Gorlach A, Brandes RP, Nguyen K, et al. A gp91 phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000;87:26-32.
9. Lassegue B, Sorescu D, Szocs K, et al. Novel gp91 (phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88:888-94.
10. De Deken X, Wang D, Many MC, et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000;275:23227-33.
11. Shiose A, Kuroda J, Tsuruya K, et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 2001;276:1417-23.
12. MacCarthy PA, Grieve DJ, Li JM, et al. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation 2001;104:2967-74.
13. Lagrand WK, Niessen HW, Wolbink GJ, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997;95:97-103.
14. Niessen HW, Kuijpers TW, Roos D, et al. Release of azurophilic granule contents in fMLP-stimulated neutrophils requires two activation signals, one of which is a rise in cytosolic free Ca2+. Cell Signal 1991;3:625-33.
15. Verhoeven AJ, Bolscher BG, Meerhof IJ, et al. Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood 1989;73:1686-94.
16. Yamauchi A, Yu L, Potgens AJ, et al. Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91 phox. Microbiol Immunol 2001;45:249-57.
17. Mallory GK, White PD, Salcedo-Salgar J. The speed of healing of myocardial infarction. Am Heart J 1939;18:647-51.
18. Cotran SC, Kumar V, Robbins LR. The heart. In: Robbins pathologic basis of disease, 4th ed. Philadelphia PA: WB Saunders, 1989:605-14.
19. Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 2000;20:1903-11.
20. Cheng G, Cao Z, Xu X, et al. Homologs of gp91 phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001;269:131-40.
21. Porter CD, Kuribayashi F, Parkar MH, et al. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis. Biochem J 1996;315:571-5.
22. Souren JE, Van Der Mast C, Van Wijk R. NADPH-oxidase-dependent superoxide production by myocyte-derived H9c2 cells: influence of ischemia, heat shock, cycloheximide and cytochalasin D. J Mol Cell Cardiol 1997;29:2803-12.
23. Suh YA, Arnold RS, Lassegue B, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999;401:79-82.
24. Bendall JK, Cave AC, Heymes C, et al. Pivotal role of a gp91 (phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002;105:293-6.
25. Zafari AM, Ushio-Fukai M, Minieri CA, et al. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid Redox Signal 1999;1:167-79.
26. Zafari AM, Ushio-Fukai M, Akers M, et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998;32:488-95.
27. Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 2001;37:676-85.